Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiangke for moderate to severe plaque psoriasis
CTR20150049Phase 2Active
- Sponsor
- Shanghai Celgen Biopharma
- Start
- Jan 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in psoriasis, sponsored by Shanghai Celgen Biopharma. Started Jan 2015; status: active.
02
Drugs
etanercept
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20150049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150049.